相关实验视频

Updated: Jun 30, 2025

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging

Published on: December 15, 2014

乳腺癌的持续转移:基于MRI的形态亚型及其临床影响

Sung Jun Ahn¹, Bio Joo¹, Mina Park¹

¹Department of Radiology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

Cancer research and treatment

|March 21, 2024

概括

乳腺癌 (BRCA) 的持续转移 (DMs) 与额外和骨转移有关. 虽然DMs不会使整体存活率恶化,但扩散的DMs会缩短leptomeningeal carcinomatosis的间隔.

科学领域:

在瘤学瘤学.
神经学神经学
放射学放射学是一门学科.

背景情况:

乳腺癌 (BRCA) 大脑转移是一个重大的临床挑战.
持续性转移 (DMs) 代表了脑部参与的独特模式.
了解影响DM的因素及其预后影响至关重要.

研究的目的:

确定与BRCA持续转移 (DMs) 相关的临床因素.
为了比较DMs的预后与单独的大脑外细胞转移 (BPMs).
分析DM亚型之间的差异及其对生存率和乳腺瘤癌 (LMC) 的影响.

主要方法:

对119名BRCA和大脑转移的患者进行了回顾性分析.
只有DM和BPM的患者之间的临床特征的比较.
卡普兰-梅尔分析DM (OSDM) 后的整体存活率和到LMC的时间.

主要成果:

脑膜炎与脑外转移和头骨转移有关.
在DM和BPM组之间没有观察到总生存时间的显著差异.
扩散型DM与光样亚型和头骨转移相关,并且与结节型DM相比,LMC的间隔较短.

结论:

长期转移在BRCA具有明显的临床关联,特别是与外和骨的参与.
虽然整体预后不会因DMs而显著改变,但亚型差异会影响进展到乳腺瘤癌.
发现有助于分层风险,并为脑转移的BRCA患者的临床管理提供信息.

关键词:

大脑转移的转移.乳腺新生体的形成.持续的转移持续的转移激素受体阳性状态转移转移转移转移预测预后预测预测追溯研究是回顾性研究.

更多相关视频

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging

Published on: June 7, 2020

Ultrasound Imaging-guided Intracardiac Injection to Develop a Mouse Model of Breast Cancer Brain Metastases Followed by Longitudinal MRI

Ultrasound Imaging-guided Intracardiac Injection to Develop a Mouse Model of Breast Cancer Brain Metastases Followed by Longitudinal MRI

Published on: March 6, 2014

相关概念视频

Magnetic Resonance Imaging

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...